These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3069434)

  • 1. Transdermal oestradiol. A recent advance in oestrogen therapy.
    Utian WH
    Drugs; 1988 Oct; 36(4):383-6. PubMed ID: 3069434
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of transdermal oestradiol (Estraderm TTS) in hypertensive postmenopausal women.
    Foidart JM
    Br J Clin Pract Suppl; 1996 Sep; 86():14-6. PubMed ID: 8995005
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal oestradiol and cardiovascular risk factors.
    Cheang A; Sitruk-Ware R; Samsioe G
    Br J Obstet Gynaecol; 1994 Jul; 101(7):571-81. PubMed ID: 8043534
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.
    Cortellaro M; Nencioni T; Boschetti C; Ortolani S; Buzzi F; Francucci B; Caraceni MP; Abelli P; Polvani F; Zanussi C
    Eur J Clin Pharmacol; 1991; 41(6):555-9. PubMed ID: 1667755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Climacteric syndrome].
    Imthurn B; Maurer-Major E
    Ther Umsch; 2000 Oct; 57(10):595-9. PubMed ID: 11081369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal versus transdermal matrix oestrogen replacement in Australasian women.
    Davis SR; Davison SL; Wilson S; Shepherd J; Lawton B
    Maturitas; 2005 Jun; 51(2):163-71. PubMed ID: 15917157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Clin Pharmacol 1998 Feb; 45 (2): 170-172.
    Kneer-Aronoff C
    J Womens Health; 1998 Oct; 7(8):1054-5. PubMed ID: 10026007
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic sensitization to 17-beta estradiol induced by transcutaneous administration].
    El Sayed F; Bayle-Lebey P; Marguery MC; Bazex J
    Ann Dermatol Venereol; 1996; 123(1):26-8. PubMed ID: 8734113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal estradiol: new formulation. Intranasal oestrogen delivery system: just a gimmick.
    Prescrire Int; 2002 Dec; 11(62):163-5. PubMed ID: 12469692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol.
    Matsui S; Yasui T; Kasai K; Keyama K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    J Obstet Gynaecol; 2017 Jul; 37(5):627-632. PubMed ID: 28317410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch.
    Liang R; Wong RW; Cheng IK
    Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in vascular flow after transdermal oestradiol therapy for prostate cancer: a mechanism for cardiovascular toxicity and benefit?
    Ockrim JL; Lalani el-N; Aslam M; Standfield N; Abel PD
    BJU Int; 2006 Mar; 97(3):498-504. PubMed ID: 16469015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high dose oestrogen therapy on circulating inflammatory markers.
    Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S
    Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oestrogel--a transdermal and convenient method of hormone replacement therapy].
    Krumov G
    Akush Ginekol (Sofiia); 2003; 42 Suppl 1():17-20. PubMed ID: 12858498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transdermal estrogen treatment. A placebo controlled study].
    Iversen OE; Eid AB; Johannesen KH; Nyland B; Løvset T
    Tidsskr Nor Laegeforen; 1991 Aug; 111(20):2544-6. PubMed ID: 1948834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of adjunctive oestrogen treatment in women with schizophrenia.
    Kulkarni J; Riedel A; de Castella AR; Fitzgerald PB; Rolfe TJ; Taffe J; Burger H
    Arch Womens Ment Health; 2002 Nov; 5(3):99-104. PubMed ID: 12510212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating dehydroepiandrosterone-sulphate decreases even with a slight change in oestradiol.
    Matsui S; Yasui T; Kasai K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    J Obstet Gynaecol; 2018 Feb; 38(2):231-235. PubMed ID: 28903616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal hormone replacement therapy, serum lipids and lipoproteins.
    Crook D; Stevenson JC
    Br J Clin Pract Suppl; 1996 Sep; 86():17-21. PubMed ID: 8995006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.